Breakthrough Discovery: Unraveling the Mechanism of Arteritis Virus Infection

According to a recent report by Xinhua News Agency, a team of American researchers has made a groundbreaking discovery in understanding the mechanism of arteritis virus infection. This breakthrough, published in the British journal Nature Communications, sheds light on the previously unknown process by which arteritis viruses infect their hosts.

Arteritis viruses are widespread among various mammals, including non-human primates, pigs, and horses. Notably, these viruses have the ability to infect a host for an extended period, increasing their virulence when transmitted to a new host. Although arteritis viruses have not been detected in humans to date, the possibility of future transmission cannot be ruled out.

Uncovering the Infection Mechanism

Researchers from Ohio State University and other institutions in the United States employed whole-genome CRISPR gene editing technology to identify the proteins used by arteritis viruses as receptors to enter host cells and replicate. After an extensive screening process, the team identified two genes, FCGRT and B2M, whose protein products form FcRn receptors and are expressed on the cell surface. FcRn receptors are present on immune cells and cells lining blood vessel walls, both of which are targets of arteritis viruses.

Experiments demonstrated that knocking out the FCGRT gene in the FcRn receptor from host cells can effectively block arteritis virus infection. Furthermore, pretreating cells with monoclonal antibodies against FcRn can also provide protection against infection. The researchers also discovered that the surface protein CD163 cooperates with the FcRn receptor to promote arteritis virus infection of host cells.

Implications and Future Directions

The researchers emphasized that understanding the mechanism of arteritis virus infection is a crucial milestone in developing corresponding treatments. This breakthrough can also help inform strategies for responding to potential future infections in humans. Additionally, the study revealed that certain mammals are less susceptible to arteritis virus infection due to their unique FcRn receptor molecule sequences.

This discovery has significant implications for the development of treatments and our understanding of the risks and response strategies associated with arteritis virus infection. As research continues to unravel the complexities of this virus, we may uncover new avenues for prevention and treatment.